Michael R. Lusignan

Array ( [id] => 5101947 [patent_doc_number] => 20070185209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Treatment methods using triaryl methane compounds' [patent_app_type] => utility [patent_app_number] => 11/642416 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12180 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185209.pdf [firstpage_image] =>[orig_patent_app_number] => 11642416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034171 [patent_doc_number] => 20070098710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Anxiolytic composition comprising essential oil derived from plants as active ingredients, anxiolytic comprising thereof, and a producing method thereof' [patent_app_type] => utility [patent_app_number] => 11/641072 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10605 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098710.pdf [firstpage_image] =>[orig_patent_app_number] => 11641072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4893987 [patent_doc_number] => 20080103086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE SECRETION OF HMGB1' [patent_app_type] => utility [patent_app_number] => 11/552945 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10125 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103086.pdf [firstpage_image] =>[orig_patent_app_number] => 11552945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688771 [patent_doc_number] => 20070105927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Amorphous rizatriptan benzoate' [patent_app_type] => utility [patent_app_number] => 11/584284 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4396 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105927.pdf [firstpage_image] =>[orig_patent_app_number] => 11584284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070382 [patent_doc_number] => 20070191484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Medicaments containing pantothenic acid' [patent_app_type] => utility [patent_app_number] => 11/526308 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6566 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191484.pdf [firstpage_image] =>[orig_patent_app_number] => 11526308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688831 [patent_doc_number] => 20070105867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof' [patent_app_type] => utility [patent_app_number] => 11/524998 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28950 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105867.pdf [firstpage_image] =>[orig_patent_app_number] => 11524998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107811 [patent_doc_number] => 20070066689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 11/516992 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1151 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066689.pdf [firstpage_image] =>[orig_patent_app_number] => 11516992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688795 [patent_doc_number] => 20070105903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs' [patent_app_type] => utility [patent_app_number] => 11/513291 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14319 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105903.pdf [firstpage_image] =>[orig_patent_app_number] => 11513291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676968 [patent_doc_number] => 20080214599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases' [patent_app_type] => utility [patent_app_number] => 11/996380 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5481 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214599.pdf [firstpage_image] =>[orig_patent_app_number] => 11996380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546755 [patent_doc_number] => 20090156632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'DOSAGE REGIMEN FOR PRASUGREL' [patent_app_type] => utility [patent_app_number] => 11/916817 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5049 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156632.pdf [firstpage_image] =>[orig_patent_app_number] => 11916817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279376 [patent_doc_number] => 20090131508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Use of 2-Oxo-1-Pyrrolidone Derivatives for the Preparation of a Drug' [patent_app_type] => utility [patent_app_number] => 11/916855 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3481 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131508.pdf [firstpage_image] =>[orig_patent_app_number] => 11916855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193566 [patent_doc_number] => 20070082050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Modified release formulations of antihypertensive drugs' [patent_app_type] => utility [patent_app_number] => 11/443671 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7166 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082050.pdf [firstpage_image] =>[orig_patent_app_number] => 11443671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700720 [patent_doc_number] => 20060217405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Interstitial cystitis treatment' [patent_app_type] => utility [patent_app_number] => 11/376555 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3809 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217405.pdf [firstpage_image] =>[orig_patent_app_number] => 11376555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667620 [patent_doc_number] => 20060172970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Methods for treatment and management of lung cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione' [patent_app_type] => utility [patent_app_number] => 11/370560 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20191 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172970.pdf [firstpage_image] =>[orig_patent_app_number] => 11370560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748454 [patent_doc_number] => 20060111386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 11/284330 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26263 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111386.pdf [firstpage_image] =>[orig_patent_app_number] => 11284330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748341 [patent_doc_number] => 20060111273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Water soluble paclitaxel derivatives' [patent_app_type] => utility [patent_app_number] => 11/253810 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24079 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111273.pdf [firstpage_image] =>[orig_patent_app_number] => 11253810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056516 [patent_doc_number] => 20050277691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Pravastatin pharmaceutical formulations and methods of their use' [patent_app_type] => utility [patent_app_number] => 11/205028 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12764 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277691.pdf [firstpage_image] =>[orig_patent_app_number] => 11205028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794076 [patent_doc_number] => 20060014757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Method for the treatment of anorexia nervosa' [patent_app_type] => utility [patent_app_number] => 11/178716 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1940 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014757.pdf [firstpage_image] =>[orig_patent_app_number] => 11178716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978621 [patent_doc_number] => 20050288339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Medicinal compositions containing diuretic and insulin resistance-improving agent' [patent_app_type] => utility [patent_app_number] => 11/165743 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 45990 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288339.pdf [firstpage_image] =>[orig_patent_app_number] => 11165743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247846 [patent_doc_number] => 20070244080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Method for Treatment of Inflammatory Disorders Using Triptolide Compounds' [patent_app_type] => utility [patent_app_number] => 11/629747 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6244 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244080.pdf [firstpage_image] =>[orig_patent_app_number] => 11629747 [rel_patent_id] =>[rel_patent_doc_number] =>)